Kingsview Wealth Management LLC acquired a new position in Corteva, Inc. (NYSE:CTVA - Free Report) in the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor acquired 12,909 shares of the company's stock, valued at approximately $1,093,000.
Several other institutional investors and hedge funds also recently bought and sold shares of the stock. EFG International AG bought a new stake in Corteva during the second quarter valued at about $25,000. Compass Financial Management LLC purchased a new position in shares of Corteva during the 2nd quarter valued at about $25,000. JPL Wealth Management LLC purchased a new stake in Corteva in the 3rd quarter worth approximately $25,000. Garton & Associates Financial Advisors LLC bought a new stake in Corteva during the 4th quarter worth approximately $27,000. Finally, Bank of Jackson Hole Trust purchased a new position in Corteva during the fourth quarter valued at approximately $28,000. 81.54% of the stock is currently owned by hedge funds and other institutional investors.
Analyst Ratings Changes
Several analysts have recently commented on the stock. JPMorgan Chase & Co. raised their price objective on shares of Corteva from $77.00 to $83.00 and gave the company a "neutral" rating in a research report on Monday, August 3rd. CICC Research raised their price target on Corteva from $80.00 to $93.00 and gave the company an "outperform" rating in a report on Wednesday, May 13th. BMO Capital Markets boosted their price objective on Corteva from $95.00 to $100.00 and gave the company an "outperform" rating in a research report on Monday, August 3rd. Mizuho lifted their target price on Corteva from $96.00 to $97.00 and gave the company an "outperform" rating in a research note on Tuesday, July 14th. Finally, BNP Paribas Exane upped their price target on Corteva from $74.00 to $77.00 in a research note on Wednesday, May 6th. Fourteen equities research analysts have rated the stock with a Buy rating and nine have assigned a Hold rating to the stock. Based on data from MarketBeat, the stock presently has a consensus rating of "Moderate Buy" and a consensus target price of $91.50.
Check Out Our Latest Research Report on Corteva
Corteva Price Performance
Shares of Corteva stock opened at $84.00 on Friday. The firm has a market cap of $56.04 billion, a PE ratio of 55.63, a PEG ratio of 2.58 and a beta of 0.57. The stock has a 50 day moving average of $82.69 and a 200 day moving average of $80.54. The company has a current ratio of 1.52, a quick ratio of 1.10 and a debt-to-equity ratio of 0.07. Corteva, Inc. has a 12 month low of $60.53 and a 12 month high of $90.97.
Corteva (NYSE:CTVA - Get Free Report) last issued its quarterly earnings data on Thursday, July 30th. The company reported $2.30 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.24 by $0.06. The business had revenue of $6.38 billion for the quarter, compared to analysts' expectations of $6.60 billion. Corteva had a return on equity of 10.18% and a net margin of 5.66%.The company's revenue for the quarter was down 1.2% on a year-over-year basis. During the same period in the prior year, the firm earned $2.20 EPS. Corteva has set its FY 2026 guidance at 3.600-3.800 EPS. On average, research analysts expect that Corteva, Inc. will post 3.72 EPS for the current fiscal year.
Corteva Dividend Announcement
The firm also recently announced a quarterly dividend, which will be paid on Tuesday, September 15th. Stockholders of record on Tuesday, September 1st will be issued a $0.18 dividend. The ex-dividend date is Tuesday, September 1st. This represents a $0.72 dividend on an annualized basis and a dividend yield of 0.9%. Corteva's payout ratio is 47.68%.
About Corteva
(
Free Report)
Corteva, Inc NYSE: CTVA is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva's operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.
Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.
Featured Articles
Want to see what other hedge funds are holding CTVA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Corteva, Inc. (NYSE:CTVA - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Before you consider Corteva, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Corteva wasn't on the list.
While Corteva currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2026. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.